Concepedia
Statistics
Publications
43
Citations
5.2K
H-Index
33
Active since
2001
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
Massachusetts General Hospital
Tufts Medical Center
VA Boston Healthcare System
Güllü Görgün is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and multiple myeloma.
Publications per year
2001–2022
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
Alan G. Ramsay, Amy J. Johnson, Abigail M. Lee et al. · Journal of Clinical Investigation · 2008 · 594 citations · Full text
Life Sciences, Immunology, Oncology +17
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma
Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 435 citations · Full text
Life Sciences, Molecular Biology, Molecular Medicine +9
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Güllü Görgün, Gregory Whitehill, Jennifer L. Anderson et al. · Blood · 2013 · 387 citations · Full text
Medicine, Immunology, Oncology +14
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Güllü Görgün, Mehmet Samur, Kristen Cowens et al. · Clinical Cancer Research · 2015 · 305 citations · Full text
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
Güllü Görgün, Tobias A.W. Holderried, David Zahrieh et al. · Journal of Clinical Investigation · 2005 · 297 citations · Full text
1–5 of 43